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ABSTRACT
BACKGROUNDAND PURPOSE: Mitochondrial neurogastrointestinal encephalopathy is a rare disorder due to recessive mutations in the
thymidine phosphorylase gene, encoding thymidine phosphorylase protein required for mitochondrial DNA replication. Clinical manifes-
tations include gastrointestinal dysmotility and diffuse asymptomatic leukoencephalopathy. This study aimed to elucidate the mecha-
nisms underlying brain leukoencephalopathy in patients with mitochondrial neurogastrointestinal encephalopathy by correlating multi-
modal neuroradiologic features to postmortem pathology.
MATERIALS ANDMETHODS: Seven patients underwent brain MR imaging, including single-voxel proton MR spectroscopy and diffusion
imaging. Absolute concentrations of metabolites calculated by acquiring unsuppressed water spectra at multiple TEs, along with diffusion
metrics based on the tensormodel, were comparedwith those of healthy controls using unpaired t tests inmultiple whitematters regions.
Brain postmortem histologic, immunohistochemical, and molecular analyses were performed in 1 patient.
RESULTS: All patients showed bilateral and nearly symmetric cerebral white matter hyperintensities on T2-weighted images, extending to the
cerebellar white matter and brain stem in 4. White matter, N-acetylaspartate, creatine, and choline concentrations were significantly reduced
compared with those in controls, with a prominent increase in the radial water diffusivity component. At postmortem examination, severe
fibrosis of brain vessel smoothmusclewas evident, alongwithmitochondrialDNA replicationdepletion inbrain andvascular smooth-muscle and
endothelial cells,withoutneuronal loss,myelindamage,orgliosis. Prominentperiependymal cytochromeCoxidasedeficiencywasalsoobserved.
CONCLUSIONS: Vascular functional and histologic alterations account for leukoencephalopathy in mitochondrial neurogastrointestinal
encephalopathy. Thymidine toxicity and mitochondrial DNA replication depletion may induce microangiopathy and blood-brain-barrier
dysfunction, leading to increased water content in the white matter. Periependymal cytochrome C oxidase deficiency could explain
prominent periventricular impairment.
ABBREVIATIONS: AD  axial diffusivity; BW  brain water; FA  fractional anisotropy; MNGIE  mitochondrial neurogastrointestinal encephalopathy; mtDNA 
mitochondrial DNA replication; MDmean diffusivity; PLIC posterior limbs of the internal capsule; PO-WM parieto-occipital white matter; RD radial diffusivity
Mitochondrial neurogastrointestinal encephalopathy (MNGIE)is a rare autosomal recessive disorder due to mutations in the
TYMP1 gene that result in thymidine phosphorylase deficiency. This
causes toxic systemic elevationof thymidine anddeoxyuridine levels,
deoxynucleotide pool imbalance, and secondary mitochondrial
DNA replication (mtDNA) abnormalities.2-5
Disease onset, typically in young adulthood, is characterized
by a slowly progressive multisystemic involvement, which in-
cludes ptosis, chronic progressive external ophthalmoplegia with
mitochondrial myopathy, demyelinating neuropathy, hearing
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loss, and, most important, severe gastrointestinal dysmotility,
leading to cachexia and diverticulosis of the small bowel.3,6
Severe mtDNA depletion is themost strikingmolecular defect
affecting several tissues (ie, smooth muscle of the gastrointestinal
wall and vasculature [small vessels]), suggesting that microvascu-
lar dysfunction may play a role in the pathogenesis.7,8 Although
the skeletalmuscle does not express thymidine phosphorylase, the
toxic nucleoside accumulation results in a typical mitochondrial
myopathy due to both depletion and accumulation of multiple
deletions of mtDNA.2 Central nervous system involvement in
MNGIE remains undercharacterized and puzzling. The brain
neuroradiologic hallmark is leukoencephalopathy, with bilateral
and symmetrically severeMR imaging signal alterations involving
mostly cerebral hemispheric white matter.9,10 Remarkably, de-
spite the extensive MR imaging alterations, most patients with
MNGIE remain asymptomatic6; brain proton MR spectroscopy
(1H-MR spectroscopy) studies of patients with MNGIE have
shown white matter biochemical alterations suggesting either
neuronal loss/dysfunction11,12 or a normal metabolic profile.13
Furthermore, a previous study reported increased water diffusiv-
ity, evaluated by diffusion-weighted MR imaging, in 4 patients
with MNGIE.12 The neuropathologic study of 2 patients with ge-
netically confirmedMNGIE did not show neuronal loss, demyeli-
nation, or glial proliferation, despite a striking loss of thymidine
phosphorylase expression in capillaries of the whitematter and an
increased intracellular albumin staining, consistent with altered
blood-brain barrier permeability.14
The purpose of this study was to elucidate the mechanisms
underlying brain leukoencephalopathy in patients with MNGIE
using a multimodal neuroradiologic and pathologic approach.
MATERIALS AND METHODS
Patients
Seven unrelated patients with amolecular diagnosis ofMNGIE (3
men; age range, 23–38 years) were included in this study.
Patients were scanned on a 1.5T MR imaging system (Signa
Horizon LX; GE Healthcare, Milwaukee, Wisconsin). Quantitative
MR imaging parameters were comparedwith those obtained from 9
healthy volunteers (4 men; age range, 20–35 years) who underwent
whitematter 1H-MRspectroscopyand from14healthyvolunteers (7
men; age range, 21–43 years)whounderwent diffusion tensor imag-
ing.Patientswereclinically assessedbyneurologic, gastroenterologic,
andnutritional evaluations. Fourpatients died, and in 1patient (case
7), a postmortem examination was performed.
The Ethics Committee of S.Orsola-Malpighi Hospital ap-
proved the study, and written informed consent was obtained.
Biochemical and Genetic Characterization
Thymidine phosphorylase activity was assessed and quantified as
previously reported. The TYMP gene was Sanger-sequenced.15
Brain MR Imaging
Conventional Brain MR Imaging Protocol Acquisition. Brain MR
imaging was performed using a quadrature birdcage head coil.
The conventional MR imaging protocol included an axial and
coronal FLAIR T2 sequence, sagittal FSE T2, and axial FSE T1-
weighted imaging.
Proton MR Spectroscopy Protocol Acquisition. A volume of in-
terest of 8 cm3 was selected in the left parieto-occipital white
matter (PO-WM).Water-suppressed protonMR spectra were ac-
quired using the point-resolved spectroscopy single-voxel local-
ization sequence (PROBE) at TE 35, 70, 100, 144, and 288 ms
(TR 4000 ms, number of acquisitions 64) to estimate the T2
ofN-acetylaspartate, creatine plus phosphocreatine, and choline-
containing compounds16 for the group of healthy controls and for
3 of 7 patients.
For the remaining 4 patients, the left PO-WM spectrum was
acquired only at TE  35 ms to limit the acquisition time to 4
minutes 16 seconds. In all subjects, unsuppressed water spectra
were also acquired at TE  25, 30, 40, 50, 60, 80, 100, 300, 600,
900, and 1000 ms; with TR  15,000 ms, as previously de-
scribed,16 to evaluate the water signal and T2 water relaxation
time.
Diffusion Tensor Imaging Protocol Acquisition. DTI was per-
formed by a single-shot echo-planar imaging sequence using 6
noncollinear directions of the diffusion gradients with the follow-
ing parameters: TR 10,000 ms, TE 107 ms, slice thickness
4 mm with a 2-mm gap, voxel size  1.25  1.25  6 mm3,
b-value 900 s/mm2.
Proton MR Spectroscopy Data Analysis. Both suppressed and
unsuppressed water spectra were processed with the fitting pro-
gram LCModel (Version 6.3; http://www.lcmodel.com/).17 The
exclusion criterion for 1H-MR spectroscopy metabolite evalua-
tion was an LCModel estimated fitting error of20%. The abso-
lute concentrations of NAA and Cho were obtained using the T2
times of the metabolites calculated by fitting the monoexponen-
tial decay of their signal in thewater-suppressed PROBE spectra at
different TEs18 and estimating the intracellular water content by
the biexponential fit of water signal amplitude of the unsup-
pressed water spectra as detailed in the On-line Appendix. We
considered a T2 relaxation value reported in the literature for
mIns (150 ms)19 because TE values used for water-suppressed
spectra acquisitions are not sufficiently short to obtain an accu-
rate signal T2-decay of this metabolite.
Diffusion Tensor Imaging Data Analysis. DTI processing was per-
formed by using the FMRIB software library (FSL; http://www.
fmrib.ox.ac.uk/fsl). DTI-EPI images were coregistered and cor-
rected for eddy current and head movement effects using the
FMRIB Linear Image Registration Tool (FLIRT; https://fsl.
fmrib.ox.ac.uk/fsl/fslwiki/FLIRT). Parameter maps for mean dif-
fusivity (MD), fractional anisotropy (FA), axial diffusivity (AD,
1), and radial diffusivity [RD, (2  3)/2] were determined
voxelwise using the program DTIFit (https://fsl.fmrib.ox.ac.uk/
fsl/fslwiki/FDT/UserGuide#DTIFIT). The EPI images were regis-
tered to the T1-weighted images using FSL tools.
To correlate theDTI-derived parameters with the biochemical
profile, we defined an ROI on the DTI using the spatial coordi-
nates of the spectroscopy volume of interest localized in the left
PO-WM. Because in this ROI, WM fibers do not have a single
predominant orientation, additional ROIs were defined on MD
map imageswithinwhitematter regionswith high fiber direction-
ality to assess changes in AD and RD with greater accuracy,
namely the optic radiations, the posterior limbs of the internal
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capsule (PLIC), and the spleniumof the corpus callosum(On-line
Fig 1). The mean values of MD, FA, AD, and RD were calculated
for each ROI.
Statistical Analysis
We first evaluated differences in demographic data between
patients and controls, using a t test or a Spearman 2 test as
appropriate. We performed a t test for unpaired data to evalu-
ate differences between patients and controls in quantitative
MR imaging values, namely metabolite concentrations, water
signals, T2brain water (BW) and T2CSF water relaxation times and
DTI parameters. Moreover, in the patient group, we per-
formed a Spearman test to evaluate the correlation between
MR spectroscopy metabolite values and DTI parameters. The
threshold for significance for all analyses was set at P  .05.
Postmortem Study
The postmortem study was performed in patient 7, eight months
after theMR imaging.Whole-body postmortem examinationwas
performed within 24 hours of death. The brain was removed and
fixed in 4% buffered formalin for neuropathologic examination.
Histologic, Histochemical, and Immunohistochemical
Analyses
Tissue specimens including frontal, temporal, parietal, occipital,
insular, and cingulate cortices; basal ganglia; thalamus; hip-
pocampus; amygdala, brain stem (midbrain, pons, medulla ob-
longata); and several blocks of cerebellar hemispheres, including
the dentate nucleus, and vermis, were obtained from formalin-
fixed brain tissue and used for histologic, histochemical, and
immunohistochemical analyses. Six-micrometer-thick sections
were stained with hematoxylin-eosin, periodic acid–Schiff, and
periodic acid—Schiff plus diastase, Luxol fast blue, congo red,
and PicroSirius Red. Immunohistochemical staining was per-
formed using a large panel of antibodies (On-line Appendix).
Molecular Analysis on Postmortem Brain Samples
Paraffin brain sections frompatient 7 and 3 age-matched controls
(subjects who underwent postmortem examination for diagnos-
tic purposes without clinical/pathologic evidence of central
nervous system diseases) were subjected to laser capture micro-
dissectionwith theMMINikonUV-CUTSystem (MolecularMa-
chines & Industries, Glattbrug, Switzerland), as previously de-
scribed20 (also see the On-line Appendix).
RESULTS
Genetic diagnosis and biochemical features of patients with
MNGIE are reported in Table 1.
MR Imaging: Bilateral Altered White Matter Signal
BrainMR imaging revealed a bilateral and nearly symmetricwhite
matter involvement characterized by hyperintensity on FLAIR T2
and FSE T2 and hypointensity on T1-weighted sequences in all
patients (Fig 1, On-line Fig 2, and On-line Table). Mild-to-severe
frontal and parieto-occipital white matter involvement was de-
tected in each patient. The temporal lobe white matter and basal
ganglia were affected in 5 patients, and the cerebellar whitematter
and brain stem, in 4. Three patients (cases 1, 2, and 3) withmilder
brain involvement showed signal intensity changes exclusively lo-
calized in the deep periventricular cerebral whitematter with nor-
mal signal intensity of the infratentorial structures.
1H-MR Spectroscopy: Reduced Cerebral White Matter
Metabolite Concentrations
In PO-WM, patients showed a significant decrease of NAA, Cr,
and Cho concentrations. mIns, which had the highest metabolite
variability in patients with MNGIE, showed a trend toward
reduced concentration (Fig 2). Metabolite ratios such as NAA/
Cr, Cho/Cr, and mIns/Cr were similar in patients and controls
(Table 2).
T2BW values, calculated from the fast decay component of
the signal from unsuppressed water acquisitions and attribut-
able to both the intracellular and intramyelin water compart-
ments, were significantly higher in patients compared with
controls (Table 3 and On-line Fig 3).
DTI: Prominent Increase of White Matter Radial
Diffusivity
In the same PO-WM region selected for the MR spectroscopy
acquisition, patients with MNGIE showed significantly higher
MD, RD, and AD as well as significantly lower FA values com-
pared with controls. The RD increase, relative to mean control
values, was more prominent than the AD increase (RD, 52%;
AD,23%). Similar results were obtained in the optic radiations.










1 23/F c.1249 dupC Frame shift Undetectable 20 yr (ptosis/CPEO) Childhood




Undetectable Childhood (CPEO) Childhood




Undetectable 24 yr (ptosis/CPEO) 20 yr
4 27/F c.1160–1GA Splice defect Very low 20 yr (ptosis/CPEO) Childhood
5 38/M c.522TA Splice defect Undetectable 37 yr (ptosis/CPEO) 30 yr
6 25/M c.1160–1GA Splice defect Very low 25 yr (peripheral
neuropathy)
19 yr
7 36/M c.457GA p. G153S Undetectable Childhood (ptosis) 25 yr
Note:—CPEO indicates chronic progressive external ophthalmoplegia; TP, thymidine phosphorylase.
a All homozygote.
b Main gastroenterologic symptoms included irritable bowel and/or functional dyspepsia-like symptoms.
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In patients with MNGIE, the difference between RD and AD
changes was even more evident in the PLIC and splenium of the
corpus callosum, where a significant increase in RD values was
associated with unchanged AD in both ROIs (Table 3).
Correlation analysis between metabolite concentrations and
DTI metrics from the same PO-WM voxel in patients with
MNGIE disclosed a negative correlation between NAA absolute
concentration and MD (r  0.82, P  .023), RD (r  0.82,
P .02), and AD values (r0.89, P .007).
Neuropathology: Fibrosis of Small-Vessel Walls and
Microbleeding
Gross examination findings of the brain and vessels of the circle of
Willis were unremarkable. Microscopic examination revealed a
moderate pallor of the deep cerebral white matter extending fo-
cally into the internal capsule and thalamic white matter, while
sparing the arcuate fibers and the corpus callosum. These
changes, however, were not associated with a significant gliosis,
neuronal loss, or axonal degeneration. The gray matter was also
unremarkable.
The most striking feature was observed at the level of small
perforating arterioles, which showed a replacement of smooth-
muscle cells of the tunica media by dense fibrous tissue (Fig 3A–
C). Loss of smooth-muscle cells was more evident in the external
layers of the tunicamedia (Fig 3B), though a total fibrous replace-
ment was observed in some vessels (Fig 3C). These features were
particularly frequent in the white matter of the frontal lobe, the
basal ganglia, and the midbrain, but absent in pial arteries (not
shown). Fibrosis was occasionally associated with concentric wall
thickening and luminal narrowing (Fig 3D). In addition, hemo-
FIG 1. MR imaging. Axial FLAIR T2 images from 2 of the 7 patients with MNGIE at the supra- and infratentorial levels. Case 1 does not show any
infratentorial involvement, while a more diffuse supra- and infratentorial signal intensity increase can be seen in case 5.
FIG 2. Proton MR spectroscopy. A, Axial FLAIR T2-weighted image shows the localization of the 8-cm3 1H-MR spectroscopy volume of interest
in the left parieto-occipital whitematter in case 5. ProtonMR spectra from the VOI in case 5 (B) and in a healthy control (C). The relative content
of metabolites is similar in the patient and healthy subject. Note the higher level of noise in the patient and smaller metabolite peaks.
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siderin-ladenmacrophages, consistentwith previousmicrobleed-
ing aspects, were observed close to fibrotic small vessels and cap-
illaries (Fig 3E). Immunohistochemical stains revealed increased
deposition of collagen IV in the basal lamina of several vessels (not
shown) and a slight perivascular gliosis (Fig 3F). The endothelial
layer, as observed by CD31 immunostaining, was unremarkable
(not shown). Immunostaining for amyloid was negative (not
shown).
Consistent with the mitochondrial etiology of the disease,
scattered neurons showed decreased expression of the mtDNA-
encoded COX I subunit. This feature was particularly evident in
the subependymal region of the lateral ventricles (not shown) and
was paralleled by mtDNA depletion in different regions of the
brain (frontal gray and white matter, and substantia nigra) and,
most important, in microdissected vascular smooth-muscle and
endothelial cells (Fig 4).
DISCUSSION
We documented that leukoencephalop-
athy, the hallmark of brain MR imaging
in MNGIE, is characterized by dilution
of all metabolites associated with a
prominent increase of the radial compo-
nent of water diffusion inmultiple white
matter regions. These results, obtained
in 7 patients, combined with the post-
mortem findings in the brain of one of
them, support the hypothesis that neu-
roradiologic abnormalities in MNGIE
result from microvascular damage. In-
deed, we found a diffuse replacement of
the vascular wall by dense fibrous tissue
and multiple perivascular microbleeds
in the whitematter of the frontal lobe, in
the basal ganglia, and in the midbrain.
Pathologic features of vessels are rem-
iniscent of those described in cerebral
microvessel disease21-23 and point to
impaired intracerebral blood flow regu-
lation and blood-brain barrier permea-
bility as synergic mechanisms leading to
increased intracellular and intramyelin
water content. The fibrosis of vascular
smooth-muscle cells is in line with that
observed in the external layer of the
muscularis propria of the gastrointesti-
nal tract,8 which is the main factor re-
sponsible for the severe dysmotility oc-
curring in most patients with MNGIE.
Analogous to observations in the mus-
cularis propria and small vessels of the
gastrointestinal wall, brain angiopathy is
also characterized by a severe mtDNA
depletion andCOXdeficiency, triggered
by the toxic effects of high circulating
levels of nucleosides.8 A previous brain
neuropathologic study of 2 patients with
MNGIE showed an increase of albumin
immunoreactivity in the cytoplasm of reactive astrocytes com-
pared with controls.14 This finding was interpreted as a result of a
functional blood-brain barrier alteration, as suggested by the em-
bryogenic role played by TYMP in glial proliferation.24
In all our patients, brain MR imaging demonstrated a typical,
diffuse (mild-to-severe) leukoencephalopathy, in striking con-
trast to the absence of clinical central nervous system involve-
ment, as observed in previously reported patients.6 In particular,
in mildly affected patients, MR imaging signal alterations were
confined to the subependymal deep cerebral white matter, while
in the severely affected patients, these changes extended to the sub-
cortical white matter, deep gray matter, and subtentorial structures.
This gradientofMRimagingwhitematter abnormalitiesparallels the
prominent COX deficiency seen in case 7 in the periependymal tis-
sue, whichmay be damaged first by high CSF levels of thymidine.
1H-MR spectroscopy of the cerebral white matter of patients
Table 2: 1H-MRS white matter parieto-occipital metabolite absolute concentrations, ratios,
and water signal intensity, and T2 values in patients with MNGIE and healthy controls
Patients with








NAA 6.98 0.79 9.81 0.94 .001a,c
Cr 4.15 0.48 5.97 0.55 .001a,c
Cho 1.53 0.23 1.89 0.24 .01a
mIns 4.46 1.14 5.44 0.76 .06a
Metabolite ratios
NAA/Cr 1.85 0.18 1.80 0.11 .57b
Cho/Cr 0.39 0.06 0.33 0.04 .04b
mIns/Cr 0.99 0.27 0.85 0.08 .16b
Water signal (a.u.)
SBW (0) (14.0 9.0)10
10 (10.8 2.0)1010 .370
SCSF (0) (4.0 7.5)10
10 (1.3 0.6)1010 .23a
T2 water
T2BW (ms) 112 24 75 8 .001
a,c
T2CSF (ms) 520 185 776 344 .098
a
Note:—a.u. indicates arbitrary units; SBW (0) and SCSF (0), water signals corresponding to brain and cerebrospinal water,
respectively; T2BW and T2CSF, water relaxation times corresponding to brain and cerebrospinal water, respectively.
a Statistical significance was set at P .0125 after Bonferroni correction for multiple comparisons.
b Statistical significance was set at P .0167 after Bonferroni correction for multiple comparisons.
c Significant.
Table 3: DTI derivate metrics in patients with MNGIE and healthy controls
ROI MD (Mean SD) FA (Mean SD) AD (Mean SD) RD (Mean SD)
PO-WM
MNGIE 1.09 0.16 0.27 0.05 1.40 0.16 0.93 0.16
Controls 0.79 0.05 0.40 0.02 1.14 0.07 0.61 0.05
P Valuea .0001b .0001b .0001b .0001b
OR
MNGIE 1.15 0.20 0.41 0.07 1.69 0.19 0.88 0.21
Controls 0.81 0.05 0.59 0.09 1.35 0.12 0.54 0.06
P Valuea .0001b .0003b .0002b .0001b
PLIC
MNGIE 0.78 0.06 0.61 0.07 1.40 0.06 0.47 0.08
Controls 0.69 0.05 0.70 0.04 1.36 0.11 0.35 0.05
P Valuea .0019b .0008b 0.36 .0003b
CC
MNGIE 0.88 0.08 0.66 0.06 1.64 0.11 0.49 0.10
Controls 0.81 0.09 0.76 0.06 1.72 0.19 .35 0.08
P Valuea .12 .0012b 0.37 .0028b
Note:—OR indicates optic radiation; CC, corpus callosum.
a Statistical significance was set at P .003 after Bonferroni correction for multiple comparisons.
b Significant.
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with MNGIE showed significant reduc-
tions of NAA, Cho, and Cr concentra-
tions. The increase of the T2 of the wa-
ter signals, derived from a slower
decay of the unsuppressed water signal
at a short TE (26–300 ms), may be at-
tributed to both intramyelinic and in-
tracellular water.25 The significant in-
crease in T2 of intracellular water of
patients compared with controls sug-
gests the enlargement of the intracellular
compartment and consequently sup-
ports the hypothesis of a dilution effect
underpinning the decreased metabolite
concentrations. Previous 1H-MR spec-
troscopy studies performed on 7 patients
with MNGIE suggested unchanged me-
tabolite ratios in the cerebral white mat-
ter.11-13 For the first time, we provide
absolute metabolite quantification by
acquiring unsuppressed water spectra at
multiple TEs, to distinguish intra- from
extracellular water.18
In our patients with MNGIE, the
DTI metrics in the same parieto-occipi-
tal voxel of the 1H-MR spectroscopy
study showed an increase of mean diffu-
sivity and a decrease of fractional anisotropy values, with a more
prominent involvement of the radial than longitudinal diffusivity.
To better estimate variations in axial and radial diffusivity, con-
sidering the abundance of white matter crossing fibers in the pa-
rieto-occipital voxel, we also evaluated DTI metrics inWM tracts
with high fiber directionality, such as the optic radiations, PLIC,
and splenium of corpus callosum. In all these structures, a prom-
inent increase of radial diffusivity was confirmed (Table 3). ROIs
of the splenium of the corpus callosum and PLIC showed a selec-
tive increase in radial diffusivity with unchanged axial diffusivity.
Radial diffusivity is considered ameasure of myelin integrity,26 as
demonstrated by its selective increase in the corpus callosum of
animalmodels with cuprizone-induced demyelination27,28 and in
the optic nerves ofmice with demyelination resulting from retinal
ischemia.29 Similarly, in patients with relapsing-remitting multi-
ple sclerosis, tract-specific DTI analysis of the optic radiations
showed selective increases in RD only within the T2 lesions and,
therefore, related to local myelin disruption.30
The absence of demyelination at postmortem examination in
one of our patients with MNGIE as well as in the other 2 previ-
ously reported cases14 points to increased intramyelin water con-
tent as the most likely explanation for prominent or selective ra-
dial diffusivity found in brain white matter structures in our
patients. A negative correlation between N-acetylaspartate con-
centration andmeandiffusivity valueswithin the samewhitemat-
ter volume was demonstrated, supporting the hypothesis of a
dilution effect as the basis of the metabolite concentration reduc-
tion, possibly affecting neuronal cells, because no correlation was
observed between any other metabolite concentration expressed
in either neural or glial cells and any DTI metrics.
FIG 3. Histologic features of brain vessels in patient 7 with MNGIE. A, Representative image of a
penetrating arteriole showing increased collagen deposition in the tunica media (arrow) (H&E,
original magnification40). B, Loss of smooth-muscle cells of the tunica media in a penetrating
vessel, especially evident at the outermost layer (smooth-muscle actin, original magnification
40). C, A thick fibrous coat completely replaces the 3-layer structure of a penetrating vessel
(PicroSirius Red, original magnification 40). D, Fibrous replacement is associated with luminal
narrowing in a small brain vessel (PicroSirius Red, original magnification 40). E, Perl iron stain
consistent with hemosiderin deposits close to a brain capillary (Perls stain, original magnification
40). F, Perivascular gliosis (glial fibrillary acidic protein, original magnification40).
FIG 4. The mtDNA amount in the brain of patient 7 with MNGIE. A,
mtDNA amount in smooth-muscle and endothelial cells microdis-
sected by laser capture from an MNGIE brain and controls (n  3)
(expressed as mtDNA copy per nucleus). B, The mtDNA amount in
different cerebral regions microdissected by laser capture from
MNGIE and controls (n 3) (expressed as mtDNA copy per nucleus).
SN indicates substantia nigra; CTR, controls.
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In addition to fibrous replacement of the vascular wall, the
neuropathologic study revealedmultiplemicrobleeds in thewhite
matter of the frontal lobe, basal ganglia, and midbrain. None of
the MNGIE T2-weighted images revealed foci of local signal loss
consistent with the presence of hemosiderin deposits,31 though
sequences such as gradient-echo T2*-weighted susceptibility-
weighted imaging, the most sensitive MR imaging for the detec-
tion of hemosiderin deposits,32 were not acquired. However, the
neuroradiologic and clinical features characterizing small-vessel
disease, such as lacunar strokes and progressive cognitive de-
cline,33 were absent in all our patients, suggesting key differences
of small-vessel involvement in MNGIE compared with other
conditions.
CONCLUSIONS
White matter metabolic and microstructural alterations detected
in patients withMNGIE can be related to microangiopathy in the
deep white matter and an energy metabolism deficit in the sub-
ependymal cells. Leukoencephalopathy in MNGIE may be the
result of endothelial failure due to thymidine toxicity andmtDNA
depletion,whichmay induce blood-brain barrier dysfunction and
microangiopathy, leading to increased white matter water con-
tent. The question of whether leukoencephalopathy is a reversible
feature cannot be solved at present. Long-term follow-up of pa-
tients with bone marrow34,35 and liver transplantation36 will
likely provide an answer.
Disclosures: Giuseppe Plazzi—UNRELATED: Board Membership: Jazz Pharmaceuti-
cals, UCB, BioProject. Roberto De Giorgio—RELATED: Grant: RF-2009-1492481 ITA
MNGIE*. Valerio Carelli—UNRELATED: Consultancy: GenSight, Santhera Pharma-
ceuticals;Other: GenSight and Santhera Pharmaceuticals,Comments: clinical trial on
Leber Hereditary Optic Neuropathy*. Michio Hirano—UNRELATED:Grant: National
Institutes of Health*, Comments: for a Phase I safety study of bone marrow trans-
plant for MNGIE. *Money paid to the institution.
REFERENCES
1. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene
mutations in MNGIE, a human mitochondrial disorder. Science
1999;283:689–92 CrossRef Medline
2. Nishigaki Y, Martí R, Copeland WC, et al. Site-specific somatic mi-
tochondrial DNA point mutations in patients with thymidine
phosphorylase deficiency. J Clin Invest 2003;111:1913–21 CrossRef
Medline
3. HiranoM, Nishigaki Y, Martí R.Mitochondrial neurogastrointesti-
nal encephalomyopathy (MNGIE): a disease of two genomes.Neu-
rologist 2004;10:8–17 CrossRef Medline
4. Spinazzola A, Marti R, Nishino I, et al. Altered thymidine metabo-
lism due to defects of thymidine phosphorylase. J Biol Chem 2002;
277:4128–33 CrossRef Medline
5. Martí R, Nishigaki Y, Hirano M. Elevated plasma deoxyuridine in
patientswith thymidinephosphorylase deficiency.BiochemBiophys
Res Commun 2003;303:14–18 CrossRef Medline
6. Garone C, Tadesse S, Hirano M. Clinical and genetic spectrum of
mitochondrial neurogastrointestinal encephalomyopathy. Brain
2011;134(Pt 11):3326–32 CrossRef Medline
7. Giordano C, Sebastiani M, Plazzi G, et al.Mitochondrial neurogas-
trointestinal encephalomyopathy: evidence ofmitochondrial DNA
depletion in the small intestine. Gastroenterology 2006;130:893–901
CrossRef Medline
8. Giordano C, Sebastiani M, De Giorgio R, et al. Gastrointestinal dys-
motility inmitochondrial neurogastrointestinal encephalomyopa-
thy is caused by mitochondrial DNA depletion. Am J Pathol 2008;
173:1120–28 CrossRef Medline
9. Nishino I, Spinazzola A, Hirano M. MNGIE: from nuclear DNA to
mitochondrial DNA. Neuromuscul Disord 2001;11:7–10 CrossRef
Medline
10. Millar WS, Lignelli A, Hirano M. MRI of five patients with mito-
chondrial neurogastrointestinal encephalomyopathy. Am J Roent-
genol 2004;182:1537–41 CrossRef Medline
11. Schu¨pbach WM, Vadday KM, Schaller A, et al. Mitochondrial neu-
rogastrointestinal encephalomyopathy in three siblings: clinical,
genetic and neuroradiological features. J Neurol 2007;254:146–53
CrossRef Medline
12. Scarpelli M, Ricciardi GK, Beltramello A, et al.The role of brainMRI
inmitochondrial neurogastrointestinal encephalomyopathy.Neu-
roradiol J 2013;26:520–30 CrossRef Medline
13. Rousset P, Elmaleh-Berge`s M, Ogier de Baulny H, et al. Mitochon-
drial neurogastrointestinal encephalomyopathy [in French]. J Neu-
roradiol 2008;35:121–24 CrossRef Medline
14. Szigeti K, Sule N, Adesina AM, et al. Increased blood-brain barrier
permeabilitywith thymidine phosphorylase deficiency.AnnNeurol
2004;56:881–86 CrossRef Medline
15. Mohamed S, Caporali L, De Giorgio R, et al. HPLC-UV analysis of
thymidine and deoxyuridine in plasma of patients with thymidine
phosphorylase deficiency. J Chromatogr B Analyt Technol Biomed
Life Sci 2014;949–950:58–62 CrossRef Medline
16. Malucelli E, Manners DN, Testa C, et al. Pitfalls and advantages of
different strategies for the absolute quantification of N-acetyl as-
partate, creatine and choline in white and grey matter by 1H-MRS.
NMR Biomed 2009;22:1003–13 Medline
17. Provencher SW. Automatic quantitation of localized in vivo 1H
spectra with LCModel. NMR Biomed 2001;14:260–64 CrossRef
Medline
18. Kreis R, Ernst T, Ross BD.Development of the human brain: in vivo
quantification of metabolite and water content with proton mag-
netic resonance spectroscopy. Magn Reson Med 1993;30:424–37
CrossRef Medline
19. Kreis R, Slotboom J, Hofmann L, et al. Integrated data acquisition
and processing to determinemetabolite contents, relaxation times,
and macromolecule baseline in single examinations of individual
subjects.Magn Reson Med 2005;54:761–68 CrossRef Medline
20. Giordano C, d’Amati G. Evaluation of gastrointestinal mtDNA de-
pletion in mitochondrial neurogastrointestinal encephalomyopa-
thy (MNGIE).Methods Mol Biol 2011;755:223–32 CrossRef Medline
21. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cere-
bral small vessel disease: insights from neuroimaging. Lancet Neu-
rol 2013;12:483–97 CrossRef Medline
22. Pantoni L. Cerebral small vessel disease: from pathogenesis and
clinical characteristics to therapeutic challenges. Lancet Neurol
2010;9:689–701 CrossRef Medline
23. Wardlaw JM.Blood-brain barrier and cerebral small vessel disease.
J Neurol Sci 2010;299:66–71 CrossRef Medline
24. Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier:
development, composition and regulation. Vascul Pharmacol 2002;
38:323–37 CrossRef Medline
25. MacKayA, Laule C, Vavasour I, et al. Insights into brainmicrostruc-
ture from the T2 distribution.Magn Reson Imaging 2006;24:515–25
CrossRef Medline
26. Aung WY, Mar S, Benzinger TL. Diffusion tensor MRI as a bio-
marker in axonal and myelin damage. Imaging Med 2013;5:427–40
CrossRef Medline
27. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial
diffusivity in corpus callosumofmouse brain.Neuroimage 2005;26:
132–40 CrossRef Medline
28. Xie M, Tobin JE, Budde MD, et al. Rostrocaudal analysis of corpus
callosum demyelination and axon damage across disease stages re-
fines diffusion tensor imaging correlations with pathological fea-
tures. J Neuropathol Exp Neurol 2010;69:704–16 CrossRef Medline
29. Sun SW, LiangHF, LeTQ, et al.Differential sensitivity of in vivo and
ex vivo diffusion tensor imaging to evolving optic nerve injury in
AJNR Am J Neuroradiol 39:427–34 Mar 2018 www.ajnr.org 433
mice with retinal ischemia.Neuroimage 2006;32:1195–204 CrossRef
Medline
30. Klistorner A, Vootakuru N, Wang C, et al. Decoding diffusivity in
multiple sclerosis: analysis of optic radiation lesional and non-le-
sional white matter. PLoS One 2015;10:e0122114 CrossRef Medline
31. Greenberg SM, Vernooij MW, Cordonnier C, et al; Microbleed Study
Group. Cerebral microbleeds: a guide to detection and interpreta-
tion. Lancet Neurol 2009;8:165–74 CrossRef Medline
32. Fazekas F, Kleinert R, Roob G, et al.Histopathologic analysis of foci
of signal loss ongradient-echoT2*-weightedMR images inpatients
with spontaneous intracerebral hemorrhage: evidence of microan-
giopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:
637–42 Medline
33. Inzitari D, Pracucci G, Poggesi A, et al; LADIS Study Group.Changes
inwhitematter as determinant of global functional decline in older
independent outpatients: three-year follow-up of LADIS (leukoarai-
osis and disability) study cohort. BMJ 2009;339:b2477 CrossRef
Medline
34. Filosto M, Scarpelli M, Tonin P, et al. Course and management of
allogeneic stem cell transplantation in patients withmitochondrial
neurogastrointestinal encephalomyopathy. J Neurol 2012;259:
2699–706 CrossRef Medline
35. Halter JP, Michael W, Schu¨pbach M, et al. Allogeneic haematopoietic
stemcell transplantation formitochondrial neurogastrointestinal en-
cephalomyopathy. Brain 2015;138:2847–58 CrossRefMedline
36. De Giorgio R, Pironi L, Rinaldi R, et al. Liver transplantation for
mitochondrial neurogastrointestinal encephalomyopathy. Ann
Neurol 2016;80:448–55 CrossRef Medline
434 Gramegna Mar 2018 www.ajnr.org
